Related Experiment Videos
Molecular basis for the autoreactivity against thyroid stimulating hormone receptor
1Cell Regulation Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
International Reviews of Immunology
|January 1, 1992
Summary
This study identifies key regions on the TSH receptor involved in autoimmune thyroid diseases like Graves' disease. Understanding these determinants helps explain organ-specific autoimmunity and disease variations.
Area of Science:
- Endocrinology and Immunology
- Molecular Biology
- Autoimmune Diseases
Background:
- Autoimmune thyroid diseases, such as Graves' disease and idiopathic myxedema, are characterized by autoantibodies targeting the TSH receptor.
- The specific determinants on the TSH receptor responsible for different autoantibody types (TSAbs and TSBAbs) and their clinical manifestations (hyper- vs. hypothyroidism) remain incompletely understood.
Purpose of the Study:
- To identify and characterize immunogenic regions and functional determinants on the TSH receptor involved in the pathogenesis of autoimmune thyroid diseases.
- To elucidate the molecular basis for organ-specific autoimmunity and differential disease expression mediated by TSH receptor autoantibodies.
Main Methods:
- Identification of immunogenic domains and functional determinants within the TSH receptor using sequence analysis and antibody interaction mapping.
- Comparative analysis of receptor determinants across species (human and rat) and related receptors (gonadotropin receptors).
- Investigation of the role of hormonal regulation and MHC class I gene expression in thyroid autoimmunity.
Main Results:
- An immunogenic domain within residues 303-382, particularly 352-366, was identified, lacking significant functional determinants.
- TSBAb and high-affinity TSH binding sites were localized to C-terminal determinants (residues 295-306, 387-395, Tyr385).
- TSAb interactions, linked to low-affinity TSH binding and signal generation, were mapped to N-terminal determinants (centered on residues 38-45, including Thr40).
Conclusions:
- Specific determinants on the TSH receptor account for organ-specific autoimmunity and distinct disease phenotypes (hypo- vs. hyperthyroidism) based on autoantibody type.
- Hormonal suppression of MHC class I genes may contribute to self-tolerance, while inappropriate MHC class I upregulation could trigger autoimmune responses.
- Methimazole and iodide may exert therapeutic effects by reducing MHC class I gene expression, suggesting a role for MHC class I regulation in autoimmune thyroid disease development.